+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Prenatal Testing & Newborn Screening Global Market Report 2021: COVID-19 Growth and Change to 2030

  • ID: 5321488
  • Report
  • May 2021
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • Baebies
  • Cradle Genomics
  • Invitae
  • PerkinElmer
  • Progenity
  • Ravgen
Prenatal Testing & Newborn Screening Global Market Report 2021: COVID-19 Growth and Change to 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global prenatal testing & newborn screening market.







This report focuses on the prenatal testing and newborn screening market which is experiencing strong growth. The report gives a guide to the prenatal testing & newborn screening market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the prenatal testing & newborn screening? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Prenatal Testing & Newborn Screening market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider prenatal testing & newborn screening market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The prenatal testing & newborn screening market section of the report gives context. It compares the prenatal testing & newborn screening market with other segments of the prenatal testing & newborn screening market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, prenatal testing & newborn screening indicators comparison.

Scope

Markets Covered:

1) By Diagnostic Type: Non-Invasive; Invasive 2) By Technology: Screening Technology; Diagnostic Technology 3) By End user: Hospitals; Diagnostic centers

Companies Mentioned: PerkinElmer; Progenity; Laboratory Corporation of America Holdings (Sequenom); Natera; Invitae

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Frequently Asked Questions about the Global Prenatal Testing & Newborn Screening Market

What is the estimated value of the Global Prenatal Testing & Newborn Screening Market?

The Global Prenatal Testing & Newborn Screening Market was estimated to be valued at $4.7 billion in 2021.

What is the growth rate of the Global Prenatal Testing & Newborn Screening Market?

The growth rate of the Global Prenatal Testing & Newborn Screening Market is 14.4%, with an estimated value of $8.0 billion by 2025.

What is the forecasted size of the Global Prenatal Testing & Newborn Screening Market?

The Global Prenatal Testing & Newborn Screening Market is estimated to be worth $8.0 billion by 2025.

Who are the key companies in the Global Prenatal Testing & Newborn Screening Market?

Key companies in the Global Prenatal Testing & Newborn Screening Market include PerkinElmer, Progenity, Laboratory Corporation of America Holdings (Sequenom), Natera, Invitae, Centogene, Cradle Genomics, Roche Diagnostics and Baebies.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Baebies
  • Cradle Genomics
  • Invitae
  • PerkinElmer
  • Progenity
  • Ravgen

1. Executive Summary2. Prenatal Testing & Newborn Screening Market Characteristics3. Prenatal Testing & Newborn Screening Market Trends and Strategies4. Impact of COVID-19 on Prenatal Testing & Newborn Screening
5. Prenatal Testing & Newborn Screening Market Size and Growth
5.1. Global Prenatal Testing & Newborn Screening Historic Market, 2015-2020, $ Billion
5.1.1. Drivers of the Market
5.1.2. Restraints on The Market
5.2. Global Prenatal Testing & Newborn Screening Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers of the Market
5.2.2. Restraints on the Market
6. Prenatal Testing & Newborn Screening Market Segmentation
6.1. Global Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Non-Invasive
  • Invasive
6.2. Global Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Screening Technology
  • Diagnostic Technology
6.3. Global Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals
  • Diagnostic centers

7. Prenatal Testing & Newborn Screening Market Regional and Country Analysis
7.1. Global Prenatal Testing & Newborn Screening Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Prenatal Testing & Newborn Screening Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8. Asia-Pacific Prenatal Testing & Newborn Screening Market
8.1. Asia-Pacific Prenatal Testing & Newborn Screening Market Overview
  • Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.3. Asia-Pacific Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
9. China Prenatal Testing & Newborn Screening Market
9.1. China Prenatal Testing & Newborn Screening Market Overview
9.2. China Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
10. India Prenatal Testing & Newborn Screening Market
10.1. India Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.2. India Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11. Japan Prenatal Testing & Newborn Screening Market
11.1. Japan Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.2. Japan Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12. Australia Prenatal Testing & Newborn Screening Market
12.1. Australia Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.2. Australia Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13. Indonesia Prenatal Testing & Newborn Screening Market
13.1. Indonesia Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.2. Indonesia Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14. South Korea Prenatal Testing & Newborn Screening Market
14.1. South Korea Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.2. South Korea Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15. Western Europe Prenatal Testing & Newborn Screening Market
15.1. Western Europe Prenatal Testing & Newborn Screening Market Overview
15.2. Western Europe Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.3. Western Europe Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16. UK Prenatal Testing & Newborn Screening Market
16.1. UK Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.2. UK Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17. Germany Prenatal Testing & Newborn Screening Market
17.1. Germany Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.2. Germany Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18. France Prenatal Testing & Newborn Screening Market
18.4. France Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.5. France Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19. Eastern Europe Prenatal Testing & Newborn Screening Market
19.1. Eastern Europe Prenatal Testing & Newborn Screening Market Overview
19.2. Eastern Europe Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.3. Eastern Europe Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20. Russia Prenatal Testing & Newborn Screening Market
20.1. Russia Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.2. Russia Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21. North America Prenatal Testing & Newborn Screening Market
21.1. North America Prenatal Testing & Newborn Screening Market Overview
21.2. North America Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.3. North America Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22. USA Prenatal Testing & Newborn Screening Market
22.1. USA Prenatal Testing & Newborn Screening Market Overview
22.2. USA Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.3. USA Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23. South America Prenatal Testing & Newborn Screening Market
23.1. South America Prenatal Testing & Newborn Screening Market Overview
23.2. South America Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.3. South America Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24. Brazil Prenatal Testing & Newborn Screening Market
24.1. Brazil Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.2. Brazil Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25. Middle East Prenatal Testing & Newborn Screening Market
25.1. Middle East Prenatal Testing & Newborn Screening Market Overview
25.2. Middle East Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.3. Middle East Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26. Africa Prenatal Testing & Newborn Screening Market
26.1. Africa Prenatal Testing & Newborn Screening Market Overview
26.2. Africa Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.3. Africa Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
27. Prenatal Testing & Newborn Screening Market Competitive Landscape and Company Profiles
27.1. Prenatal Testing & Newborn Screening Market Competitive Landscape
27.2. Prenatal Testing & Newborn Screening Market Company Profiles
27.2.1. PerkinElmer
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Progenity
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Laboratory Corporation of America Holdings (Sequenom)
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Natera
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Invitae
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers and Acquisitions in the Prenatal Testing & Newborn Screening Market29. Prenatal Testing & Newborn Screening Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Baebies
  • Cradle Genomics
  • Invitae
  • PerkinElmer
  • Progenity
  • Ravgen
Major players in the prenatal testing and newborn screening tests market are PerkinElmer, Progenity, Laboratory Corporation of America Holdings (Sequenom), Natera, Invitae, Centogene, Cradle Genomics, Roche Diagnostics, Quest Diagnostics, and Baebies.

The global prenatal testing & newborn screening market is expected to grow from $4.178 billion in 2020 to $4.679 billion in 2021 at a compound annual growth rate (CAGR) of 12%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $8.018 billion in 2025 at a CAGR of 14%.

The prenatal testing and newborn screening tests market consists of sales of prenatal testing and newborn screening tests services and related goods by entities (organizations, sole traders and partnerships) that provide prenatal testing and newborn screening tests, which help to determine various genetic and chromosomal diseases, to provide timely medical or surgical treatment of a condition before or after birth. Genetic diseases such as sickle cell, down’s syndrome, cystic fibrosis and muscular dystrophy are detected with the help of these tests. Only goods and services traded between entities or sold to end consumers are included.

The use of machine learning and artificial intelligence is gradually gaining popularity in the prenatal testing and newborn screening market. Artificial intelligence (AI) is the simulation of human intelligence in machines. Machine learning is a part of AI. Machine learning and AI help companies in the prenatal testing and newborn screening market to conduct a detailed analysis of all relevant data, provide insights about different diseases, and offer a more accurate evaluation of tissue samples. For instance, in December 2017, Eone-Diagnomics Genome Center (EDGC), a Korean genetic analysis company, announced its decision to apply machine learning-based artificial intelligence (AI) technology to its non-invasive prenatal test (NIPT) NICE®0. In 2019, AI specialist FDNA and PerkinElmer Genomics partnered to launch Face2Gene Labs for newborn testing.

The prenatal testing and newborn screening market covered in this report is segmented by diagnostic type into non-invasive; invasive. It is also segmented by technology into screening technology; diagnostic technology, and by end user into hospitals; diagnostic centers.

Growth of the prenatal testing and newborn screening market may be hampered by the relatively low healthcare access in most developing countries, compared to the developed nations. For instance, in India, there were only about 1.9 million hospital beds for 1.33 billion people, as of 2020. Low access to healthcare services and the lack of sufficient hospitals and healthcare professionals harmed market growth in many developing nations. Moreover, low disposable income in many countries further lowers the access to healthcare services, thus negatively hampering the growth of the prenatal testing and newborn screening market.

In March 2020, Thermo Fisher Scientific Inc announced its decision to acquire Qiagen for $11.5 billion. Thermo Fisher has a specialty diagnostics capability, that includes allergy, autoimmunity, transplant diagnostics, and oncology testing. The acquisition is expected to complement the Thermo Fisher’s genetic analysis and bioscience capabilities. Qiagen is a Germany-based genetic tester that was founded in 1984 and operates more than 35 offices in over 25 countries.

The high prevalence of genetic diseases in infants contributed to the growth of the prenatal testing and newborn screening market. According to the World Health Organization, genetic disease includes diseases such as Thalassemia, Sickle Cell Anaemia, Haemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, Huntington’s disease. The sickle cell anaemia is one of the genetic diseases that affects millions throughout the world, and the disease is particularly common among people whose ancestors are from Africa, America, Cuba, Central America, Saudi Arabia, India. According to a 2019 study, the disease occurs for 1 in every 500 African American births, and 1 in 12 African-American carry the sickle cell allele. The high prevalence of genetic diseases in infants boosted the demand for prenatal testing and newborn screening market.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • PerkinElmer
  • Progenity
  • Laboratory Corporation of America Holdings (Sequenom)
  • Natera
  • Invitae
  • Centogene
  • Cradle Genomics
  • Roche Diagnostics
  • Quest Diagnostics
  • Baebies
  • Progenity
  • Ravgen
  • Strand life sciences
  • Eurofins scientific
Note: Product cover images may vary from those shown

Loading
LOADING...